Learning Objectives:

1. To establish whether the primary end point was the incidence of hypophosphatemia between baseline and day 35.

2. To determine clinical significance of study results.

Session date: 
06/04/2021 - 12:00pm to 1:00pm CDT
Zoom meeting
5700 S Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mohammed Nasaruddin, MD